DHR Young Scientist, at Jamia Millia Islamia, India.
Dr. Anam Ashraf is a dynamic and accomplished researcher with a Ph.D. in Life Sciences, specializing in molecular and structural biology, drug discovery, and research communication. Her scholarly journey spans prestigious institutions like the National Institute of Immunology and Jamia Millia Islamia. With a flair for both benchwork and penwork, Dr. Ashraf excels in scientific writing, grant proposals, and research translation. She has significantly contributed to the understanding of pathogen biology, cancer therapeutics, and microbial resistance. Her collaborative projects and high-impact publications reflect her innovative mindset and interdisciplinary approach. As a co-corresponding author on multiple articles, she demonstrates leadership and scientific clarity. Dr. Ashraf continues to bridge the gap between complex molecular mechanisms and translational science, aspiring to channel her research acumen into impactful scientific writing and policy communication. She brings passion, precision, and purpose to every project she undertakes. 📚💡
Professional Profile
Scopus
ORCID
🎓 Education
Dr. Anam Ashraf’s academic foundation is rooted in premier Indian institutions, beginning with a Bachelor’s in Biotechnology from Jamia Millia Islamia (2010–2013), where she cultivated her interest in molecular biology. She then pursued an M.Sc. in Biotechnology from South Asian University (2013–2015), engaging in research on microRNA-181a and its role in liver fibrosis. Her scholarly trajectory culminated in a Ph.D. from the National Institute of Immunology (2015–2021), focusing on the mechanistic properties of the enzyme HisI and histidine biosynthesis dynamics in Mycobacterium tuberculosis. During her doctoral research, Dr. Ashraf developed deep expertise in structural biology, molecular dynamics, and host-pathogen interactions. Her academic record is complemented by her qualification of the highly competitive DBT-JRF (Category I) national-level examination in 2015. Each stage of her education has honed her analytical thinking, experimental rigour, and communication skills, making her a standout scholar in the life sciences domain. 🎓🔬
🧪 Experience
Dr. Anam Ashraf’s professional journey reflects over a decade of laboratory and academic excellence. Currently serving as a DHR-Young Scientist at Jamia Millia Islamia (since September 2022), she previously held a Senior Research Fellowship (SRF) there from 2021 to 2022. Her experience encompasses structural analysis of enzymes, inhibitor screening, and molecular dynamics simulations. Dr. Ashraf’s diverse skill set includes scientific manuscript writing, bioinformatics, grant proposal development, and public speaking. She has played key roles in multiple interdisciplinary research teams, contributing as both experimentalist and co-corresponding author. Her collaborative work spans microbiology, oncology, and computational biology, positioning her at the forefront of translational biomedical research. Dr. Ashraf’s research outputs have been presented at leading global forums and published in prestigious journals. Her combination of scientific depth and communicative clarity makes her uniquely qualified for both research-intensive and science communication roles. 🧫🧠
🔍 Research Interests
Dr. Anam Ashraf’s research interests lie at the confluence of molecular biology, structural biology, and computational drug discovery. Her doctoral work on Mycobacterium tuberculosis explored enzyme dynamics in host infection contexts, laying a foundation for antimicrobial development. Passionate about solving real-world biomedical challenges, she actively explores oxidative stress pathways, transcriptional regulation in pathogens, and cancer therapeutics via natural compound screening. She is particularly interested in structure-guided drug design, using techniques like X-ray crystallography, molecular docking, and MD simulations. Her recent focus on targeting proteins like RfaH and Aurora Kinase B with plant-derived compounds reflects a translational vision for therapy. Additionally, Dr. Ashraf is intrigued by the gut-brain axis, microbial endocrinology, and the interface between microbiota and host metabolism. Her interdisciplinary expertise empowers her to dissect complex mechanisms and identify novel therapeutic targets. Her work exemplifies how basic science can fuel next-generation treatment strategies. 🔬💊🧠
🏆 Awards
Dr. Anam Ashraf has garnered numerous accolades throughout her academic and research career. She qualified for the prestigious DBT-JRF Category I examination in 2015, which supported her doctoral research at the National Institute of Immunology. Her oral and poster presentations have been recognized at both national and international platforms, including the AsCA 2024 Conference in Malaysia, Keystone Symposia in the USA, and INCD 2023 in Chandigarh, where her innovative work on antimicrobial and cancer therapeutics was spotlighted. Her selection as a DHR-Young Scientist further reflects the national recognition of her scientific contributions. Dr. Ashraf’s ability to distill complex research into accessible formats has also earned her commendation in interdisciplinary forums such as “Global Bio-India” and “Biophysika.” Her consistent presence at high-impact events demonstrates not only her scientific merit but also her commitment to disseminating knowledge across academia and industry. 🥇📢
📚Top Noted Publications
Dr. Anam Ashraf has published extensively in high-impact journals, with over 19 peer-reviewed articles, several as co-corresponding or equal author. Her publications span antimicrobial research, structural biology, oncology, and microbial endocrinology.
🔬 Structural Biology & Enzymology
-
Crystal Structure of Thymidine Kinase
-
Authors: [Authors not specified]
-
Journal: BBA – Proteins and Proteomics
-
Year: 2025
-
Citations: 5+
-
DOI: [DOI not available]PubMed+6PubMed+6Frontiers+6PubMed+11PubMed+11Directory of Open Access Journals – DOAJ+11
-
Structure-Guided Identification of MTH1 Inhibitors
-
PDB Structure Submission
-
Conformational Switch in PIM-1
-
Authors: [Authors not specified]
-
Journal: Computational Biology and Chemistry
-
Year: 2024
-
Citations: 2
-
DOI: [DOI not available]PubMed+6PubMed+6Frontiers+6Frontiers+10PubMed+10PubMed+10
-
Effect of pH on TK Enzyme
🧬 Molecular Mechanisms & Disease Links
-
Role of MTH1 in Oxidative Stress and Therapeutic Targeting of Cancer
-
Microbial Endocrinology and Metabolism
-
Authors: [Authors not specified]
-
Journal: Molecular and Cellular Endocrinology
-
Year: 2024
-
Citations: 1
-
DOI: [DOI not available]PubMed+9PubMed+9ResearchGate+9Frontiers+4PubMed+4SpringerLink+4
-
Targeting Transcriptional Regulatory Protein RfaH with Natural Compounds to Develop Novel Therapies Against Klebsiella pneumoniae
-
Authors: Anam Ashraf, Arunabh Choudhary, Mohammad Ali Khan, Saba Noor, Afzal Hussain, Mohamed F. Alajmi, Md Imtaiyaz Hassan
-
Journal: Journal of Biomolecular Structure and Dynamics
-
Year: 2024
-
DOI: 10.1080/07391102.2024.2427376Taylor & Francis Online+1ResearchGate+1
-
Repurposing Rifaximin
🧪 Drug Discovery & Natural Compound Research
-
Investigating the Chemo-Preventive Role of Noscapine in Lung Carcinoma via Therapeutic Targeting of Human Aurora Kinase B
-
Authors: [Authors not specified]
-
Journal: Molecular and Cellular Biochemistry
-
Year: 2024
-
Citations: 3
-
DOI: 10.1007/s11010-024-05036-7
-
Probing Baicalin as Potential Inhibitor of Aurora Kinase B: A Step Towards Lung Cancer Therapy
-
Authors: Noor Saba, Arunabh Choudhury, Ali Raza, Anam Ashraf
-
Journal: International Journal of Biological Macromolecules
-
Year: 2024
-
DOI: 10.1016/j.ijbiomac.2023.128813
-
Natural Compounds vs. Klebsiella
-
CDK5 as Neuro Target
-
Triazole Inhibitor for Mycobacterium tuberculosis
🧫 Tuberculosis & Metabolic Studies
-
Histidine Biosynthesis in TB
-
Lipid Utilization in TB
-
Bacterioferritin Structure
🫁 Disease-Focused Studies
-
Molecular Blueprint of COPD
-
Mineral Pitch and Cancer
Conclusion
Dr. Anam Ashraf is highly suitable for the Research for Women Researcher Award, particularly based on:
-
Her consistent and impactful contributions to life sciences,
-
Strong publication and presentation record in relevant domains,
-
And her leadership in scientific writing, drug discovery, and structural biology.
With modest improvements in formal recognitions, mentorship visibility, and community science engagement, she could emerge as a leading candidate not only for this award but for broader international recognition.